NCT00959439View on ClinicalTrials.gov

Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

May 31, 2002

Study Completion Date

May 31, 2002

Conditions
Rheumatoid ArthritisOsteoarthritis
Interventions
DRUG

Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.)

DRUG

Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY